全文获取类型
收费全文 | 22665篇 |
免费 | 2622篇 |
国内免费 | 442篇 |
专业分类
耳鼻咽喉 | 396篇 |
儿科学 | 1588篇 |
妇产科学 | 1167篇 |
基础医学 | 2584篇 |
口腔科学 | 288篇 |
临床医学 | 2373篇 |
内科学 | 2860篇 |
皮肤病学 | 182篇 |
神经病学 | 1621篇 |
特种医学 | 513篇 |
外国民族医学 | 3篇 |
外科学 | 1467篇 |
综合类 | 1463篇 |
现状与发展 | 3篇 |
预防医学 | 3266篇 |
眼科学 | 542篇 |
药学 | 2235篇 |
18篇 | |
中国医学 | 408篇 |
肿瘤学 | 2752篇 |
出版年
2024年 | 94篇 |
2023年 | 549篇 |
2022年 | 858篇 |
2021年 | 1135篇 |
2020年 | 1150篇 |
2019年 | 1143篇 |
2018年 | 1041篇 |
2017年 | 1034篇 |
2016年 | 1093篇 |
2015年 | 1047篇 |
2014年 | 1535篇 |
2013年 | 2225篇 |
2012年 | 1243篇 |
2011年 | 1287篇 |
2010年 | 1040篇 |
2009年 | 1016篇 |
2008年 | 1033篇 |
2007年 | 987篇 |
2006年 | 808篇 |
2005年 | 710篇 |
2004年 | 610篇 |
2003年 | 569篇 |
2002年 | 420篇 |
2001年 | 385篇 |
2000年 | 288篇 |
1999年 | 289篇 |
1998年 | 264篇 |
1997年 | 242篇 |
1996年 | 186篇 |
1995年 | 177篇 |
1994年 | 156篇 |
1993年 | 133篇 |
1992年 | 146篇 |
1991年 | 108篇 |
1990年 | 97篇 |
1989年 | 73篇 |
1988年 | 85篇 |
1987年 | 69篇 |
1986年 | 59篇 |
1985年 | 69篇 |
1984年 | 51篇 |
1983年 | 46篇 |
1982年 | 36篇 |
1981年 | 31篇 |
1980年 | 29篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
Mutations in the human fibrillin 1 gene (FBN1) cause the Marfan syndrome (MFS), an autosomal dominant connective tissue disorder. Knowledge about FBN1 mutations is important for early diagnosis, management, and genetic counseling. However, mutation detection in FBN1 is a challenge because the gene is very large in size ( approximately 200 kb) and the approximately 350 mutations detected so far are scattered over 65 exons. Conventional methods for large-scale detection of mutations are expensive, technically demanding, or time consuming. Recently, a high-capacity low-cost mutation detection method was introduced based on denaturing high-performance liquid chromatography (DHPLC). To assess the sensitivity and specificity of this method, we blindly screened 64 DNA samples of known FBN1 genotype exon-by-exon using exon-specific DHPLC conditions. Analysis of 682 PCR amplicons correctly identified 62 out of 64 known sequence variants. In three MFS patients of unknown FBN1 genotype, we detected two mutations and eight polymorphisms. Overall, 20 mutations and two polymorphisms are described here for the first time. Our results demonstrate 1) that DHPLC is a highly sensitive (89-99%, P = 0.05) method for FBN1 mutation detection; but 2) that chromatograms with moderate and weak pattern abnormalities also show false positive signals (in all 45-59%, P = 0.05); 3) that the difference in the chromatograms of heterozygous and homozygous amplicons is mostly independent of the type of sequence change; and 4) that DHPLC column conditions, additional base changes, and the amounts of injected PCR products influence significantly the shape of chromatograms. A strategy for FBN1 mutation screening is discussed. 相似文献
103.
Lois J. Starr Jürgen W. Spranger Vamshi K. Rao Richard Lutz Anji T. Yetman 《American journal of medical genetics. Part A》2019,179(7):1270-1275
PIGQ (OMIM *605754) encodes phosphatidylinositol glycan biosynthesis class Q (PIGQ) and is required for proper functioning of an N‐acetylglucosamine transferase complex in a similar manner to the more established PIGA, PIGC, and PIGH. There are two previous patients reported with homozygous and apparently deleterious PIGQ mutations. Here, we provide the first detailed clinical report of a patient with heterozygous deleterious mutations associated with glycosylphosphatidylinositol‐anchored protein (GPI‐AP) biosynthesis deficiency. Our patient died at 10 months of age. The rare skeletal findings in this disorder expand the differential diagnosis of long bone radiolucent lesions and sphenoid wing dysplasia. This clinical report describes a new and rare disorder—PIGQ GPI‐AP biosynthesis deficiency syndrome. 相似文献
104.
The ethical and legal issues arising from genetic screening in embryo donation are discussed in relation to two recent cases where embryos with uncertain genetic health were offered for donation. 相似文献
105.
Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants 总被引:4,自引:0,他引:4
A study involving more than 2,000 infants was conducted in Vietnam to assess the field effectiveness and immunogenicity of recombinant hepatitis B vaccine given at birth, 1 month, 2 months, without concomitant hepatitis B immune globulin (HBIG). All received a 5 microg dose of H-B-VAX II at birth. Infants born to non-carrier mothers (Group 1; N = 1798) then received 2.5 microg doses at 1 and 2 months of age, while infants of HBeAg-negative (Group 2; N = 125) or HBeAg-positive (Group 3; N = 88) carrier mothers received 5 microg doses. No Group 1 or 2 vaccinees were infected. In Group 3, 12 (14.6%) of 82 infants did become infected (estimated efficacy 84%). 98.0-98.6% of uninfected infants who were tested for anti-HBs developed a seroprotective concentration > or = 10 IU/L. In hyperendemic Vietnam, where routine maternal screening and passive-active prophylaxis of high-risk infants with vaccine plus HBIG is not feasible, administration of vaccine alone to all newborns may control effectively HBV infection. 相似文献
106.
Simon Gilbody David Richards Michael Barkham 《The British journal of general practice》2007,57(541):650-652
There is increased emphasis on routine assessment of depression in primary care. This report is the first UK validation of two self-completed measures: the Patient Health Questionnaire (PHQ-9) and the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM). Optimum cut-off points were established against a diagnostic gold standard in 93 patients. PHQ-9 sensitivity = 91.7% (95% confidence interval [CI] = 77.5 to 98.3%) and specificity 78.3% (95% CI = 65.8 to 87.9%). CORE-OM sensitivity = 91.7% (95% CI = 77.5 to 98.2%) and specificity = 76.7% (95% CI = 64.0 to 86.6%). Brief self-rated questionnaires are as good as clinician-administered instruments in detecting depression in UK primary care. 相似文献
107.
Megan E. Rech John M. McCarthy Chun‐An Chen Jane C. Edmond Veeral S. Shah Daniëlle G. M. Bosch Gerard T. Berry Linford Williams Suneeta Madan‐Khetarpal Dmitriy Niyazov Charles Shaw‐Smith Erin M. Kovar Philip J. Lupo Christian P. Schaaf 《American journal of medical genetics. Part A》2020,182(6):1426-1437
Bosch–Boonstra–Schaaf Optic Atrophy Syndrome (BBSOAS) is an autosomal dominant neurodevelopmental disorder caused by loss‐of‐function variants in NR2F1 and characterized by visual impairment, developmental delay, and intellectual disability. Here we report 18 new cases, provide additional clinical information for 9 previously reported individuals, and review an additional 27 published cases to present a total of 54 patients. Among these are 22 individuals with point mutations or in‐frame deletions in the DNA‐binding domain (DBD), and 32 individuals with other types of variants including whole‐gene deletions, nonsense and frameshift variants, and point mutations outside the DBD. We corroborate previously described clinical characteristics including developmental delay, intellectual disability, autism spectrum disorder diagnoses/features thereof, cognitive/behavioral anomalies, hypotonia, feeding difficulties, abnormal brain MRI findings, and seizures. We also confirm a vision phenotype that includes optic nerve hypoplasia, optic atrophy, and cortical visual impairment. Additionally, we expand the vision phenotype to include alacrima and manifest latent nystagmus (fusional maldevelopment), and we broaden the behavioral phenotypic spectrum to include a love of music, an unusually good long‐term memory, sleep difficulties, a high pain tolerance, and touch sensitivity. Furthermore, we provide additional evidence for genotype–phenotype correlations, specifically supporting a more severe phenotype associated with DBD variants. 相似文献
108.
A mass screening programme for cervical cancer is in progress in three pilot regions in The Netherlands. All women living in these regions aged 35-53 are invited to undergo screening at three-year intervals. The MISCAN simulation model was developed for the analysis and optimization of screening programmes. In this paper the model-based approach to evaluation is first outlined and then illustrated by analysing data from the first two screening rounds in the pilot regions. This analysis resulted in a rather restricted range of data-compatible assumptions for the mean duration of preclinical disease (14-19 yr) and the frequency of spontaneous regression of preinvasive lesions (45-65%), as well as a rather wide sensitivity range for the Pap smear (50-90%). These preliminary findings are compared with those of a previous MISCAN analysis of cervical cancer screening in British Columbia. On the basis of an assumed 18-yr duration, 50% regression and 70% sensitivity, a number of screening policies relating to the same age ranges but with different intervals are compared. Both the analysis and the policy comparisons are preliminary, but the findings are nevertheless reasonable and consistent with those of previous studies. A more complete MISCAN-based analysis of the Dutch screening programme and subsequent optimization of screening policies will be possible when further results become available and a cost-effectiveness analysis procedure has been incorporated into the MISCAN programme. 相似文献
109.
Emily Stephenson Simone Webb Prof. Muzlifah Haniffa 《European journal of immunology》2021,51(4):764-772
The development of the human immune system during embryonic and fetal life has historically been difficult to research due to limited access to human tissue. Experimental animal models have been widely used to study development but cellular and molecular programmes may not be conserved across species. The advent of multiomic single-cell technologies and an increase in human developmental tissue biobank resources have facilitated single-cell multiomic studies focused on human immune development. A critical question in the near future is "How do we best reconcile scientific findings across multiple omic modalities, developmental time, and organismic space?" In this review, we discuss the application of single-cell multiomic technologies to unravel the major cellular lineages in the prenatal human immune system. We also identify key areas where the combined power of multiomics technologies can be leveraged to address specific immunological gaps in our current knowledge and explore new research horizons in human development. 相似文献
110.
目的差异筛选人肝癌凋亡细胞cDNA文库。方法消减杂交和点杂交相结合的噬菌斑原位杂交法筛选cDNA文库,首先采用(-)cDNA探针杂交,挑取(-)的噬菌斑克隆,再用(-)和(+)两种cDNA探针与初筛出的噬菌斑克隆杂交的差异筛选方法。结果得到4个充分孤立的噬菌斑克隆,其插入片段长度为1.5kb左右。结论该方法简便、快速,是差异筛选cDNA文库的一种较为可行的简便方法。 相似文献